Cargando…

Fortifying p53 – beyond Mdm2 inhibitors

Detalles Bibliográficos
Autores principales:	Sriraman, Anusha, Li, Yizhu, Dobbelstein, Matthias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5076439/ https://www.ncbi.nlm.nih.gov/pubmed/27688014 http://dx.doi.org/10.18632/aging.101073

Ejemplares similares

Mdm2 inhibition confers protection of p53-proficient cells from the cytotoxic effects of Wee1 inhibitors
por: Li, Yizhu, et al.
Publicado: (2015)

CDK4 inhibition diminishes p53 activation by MDM2 antagonists
por: Sriraman, Anusha, et al.
Publicado: (2018)

Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity
por: Sriraman, Anusha, et al.
Publicado: (2016)

MDM2-Driven Ubiquitination Rapidly Removes p53 from Its Cognate Promoters
por: Henningsen, Kester Mo, et al.
Publicado: (2021)

Mdm2: Open questions
por: Dobbelstein, Matthias, et al.
Publicado: (2020)

Wee1 and Chk1 – crosstalk between key players in replicative stress
por: Saini, Priyanka, et al.
Publicado: (2015)

The Dual Interactions of p53 with MDM2 and p300: Implications for the Design of MDM2 Inhibitors
por: Kannan, Srinivasaraghavan, et al.
Publicado: (2019)

Mdm2 as a chromatin modifier
por: Wienken, Magdalena, et al.
Publicado: (2017)

Have the roles of two functional polymorphisms in breast cancer, R72P in P53 and MDM2-309 in MDM2, become clearer?
por: Scott, Rodney J
Publicado: (2010)

Artificial Macrocycles as Potent p53–MDM2 Inhibitors
por: Estrada-Ortiz, Natalia, et al.
Publicado: (2017)

Control of the Mdm2-p53 signal loop by β-arrestin 2: The ins and outs
por: Blondel-Tepaz, Elodie, et al.
Publicado: (2021)

Energetic Landscape of MDM2-p53 Interactions by Computational Mutagenesis of the MDM2-p53 Interaction
por: Thayer, Kelly M., et al.
Publicado: (2016)

Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials
por: Zhu, Haohao, et al.
Publicado: (2022)

Detection of P53 and Mdm2 in vitiligo
por: Wiwanitkit, Viroj
Publicado: (2013)

The MDM2-p53 pathway revisited
por: Nag, Subhasree, et al.
Publicado: (2013)

Evolution of the p53-MDM2 pathway
por: Åberg, Emma, et al.
Publicado: (2017)

Regulation of p53: a collaboration between Mdm2 and MdmX
por: Pei, Dongsheng, et al.
Publicado: (2012)

Regulation of kidney development by the Mdm2/Mdm4–p53 axis
por: El-Dahr, Samir, et al.
Publicado: (2017)

8-Triazolylpurines: Towards Fluorescent Inhibitors of the MDM2/p53 Interaction
por: Pettersson, Mariell, et al.
Publicado: (2015)

Small-Molecule Inhibitors of the MDM2–p53 Protein–Protein Interaction (MDM2 Inhibitors) in Clinical Trials for Cancer Treatment: Miniperspective
por: Zhao, Yujun, et al.
Publicado: (2014)

Heterogeneous Hydration of p53/MDM2 Complex
por: Guo, Zuojun, et al.
Publicado: (2014)

Benzimidazoles Downregulate Mdm2 and MdmX and Activate p53 in MdmX Overexpressing Tumor Cells
por: Mrkvová, Zuzana, et al.
Publicado: (2019)

Novel Allosteric Mechanism of Dual p53/MDM2 and p53/MDM4 Inhibition by a Small Molecule
por: Grinkevich, Vera V., et al.
Publicado: (2022)

Structural Basis of Competitive Recognition of p53 and MDM2 by HAUSP/USP7: Implications for the Regulation of the p53–MDM2 Pathway
por: Hu, Min, et al.
Publicado: (2006)

Circular RNA CDR1as disrupts the p53/MDM2 complex to inhibit Gliomagenesis
por: Lou, Jiacheng, et al.
Publicado: (2020)

Diaryl- and triaryl-pyrrole derivatives: inhibitors of the MDM2–p53 and MDMX–p53 protein–protein interactions
por: Blackburn, Tim J., et al.
Publicado: (2013)

Human Glioblastoma Multiforme: p53 Reactivation by a Novel MDM2 Inhibitor
por: Costa, Barbara, et al.
Publicado: (2013)

Recent Small-Molecule Inhibitors of the p53–MDM2 Protein–Protein Interaction
por: Beloglazkina, Anastasia, et al.
Publicado: (2020)

Protoporphyrin IX is a dual inhibitor of p53/MDM2 and p53/MDM4 interactions and induces apoptosis in B-cell chronic lymphocytic leukemia cells
por: Jiang, Liren, et al.
Publicado: (2019)

The RP-Mdm2-p53 Pathway and Tumorigenesis
por: Miliani de Marval, Paula L., et al.
Publicado: (2011)

Controlling the Mdm2-Mdmx-p53 Circuit
por: Waning, David L., et al.
Publicado: (2010)

Immunohistochemical detection of P53 and Mdm2 in vitiligo
por: Bakry, Ola A., et al.
Publicado: (2012)

Reactivation of p53 via MDM2 inhibition
por: Kim, E S, et al.
Publicado: (2015)

Interchanging heads: p53 re-composes the DREAM/MMB complex to repress transcription
por: Dobbelstein, Matthias
Publicado: (2013)

Design, Synthesis and Evaluation of 2,5-Diketopiperazines as Inhibitors of the MDM2-p53 Interaction
por: Pettersson, Mariell, et al.
Publicado: (2015)

p53 pathway dysfunction in AML: beyond TP53 mutations
por: Post, Sean M., et al.
Publicado: (2017)

A Call for Explainer/Tutorial Articles and Changes to Manuscript Submission and Review at MDM and MDM P&P
por: Zikmund-Fisher, Brian J.
Publicado: (2020)

The p53–Mdm2 interaction and the E3 ligase activity of Mdm2/Mdm4 are conserved from lampreys to humans
por: Coffill, Cynthia R., et al.
Publicado: (2016)

An Application of Fit Quality to Screen MDM2/p53 Protein-Protein Interaction Inhibitors
por: Xue, Xin, et al.
Publicado: (2018)

ODP281 JDP2 Interacts with MDM2 and Decreases MDM2-Mediated p53 Repression
por: Yang, William, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tgrh08d9hqrv2gj0qp453jdtac